Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus
MetadataShow full item record
Objective The objective of this study was to assess Modified Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and European Consensus Lupus Activity Measurement (ECLAM) disease activity correlation in addition to their respective correlation to Pediatric Systemic Lupus International Collaborative Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (Ped-SDI), in juvenile systemic lupus erythematosus (JSLE). Methods The activity indices were scored retrospectively and summarized by adjusted means during follow-up. The Ped-SDI was scored during the last visit for those with more than six months follow-up. Pearson correlation between the Modified SLEDAI-2K and ECLAM, as well as Spearman correlations between the Modified SLEDAI-2K, ECLAM, and Ped-SDI were calculated. The receiver operating characteristic (ROC) curve was calculated for both activity indices discriminating damage measured by Ped-SDI. Results Thirty-seven patients with mean age at diagnosis 11 ± 2.9 years and mean follow-up time 3.2 ± 2.4 years were studied. The Modified SLEDAI-2K and ECLAM adjusted means were highly correlated (r = 0.78, p < 0.001). Similarly, Spearman correlation between the activity indices was also high (rs > 0.7, p < 0.001), but Modified SLEDAI-2K and ECLAM correlation with Ped-SDI was only moderate. ROC analysis discriminant performance for both activity indices resulted in area under curve (AUC) of 0.74 and 0.73 for Modified SLEDAI-2K and ECLAM, respectively. Conclusion The high correlation found between the Modified SLEDAI-2K and ECLAM adjusted means indicated that both tools can be equally useful for longitudinal estimates of JSLE activity.
How to cite this document
Showing items related by title, author, creator and subject.
Correlation between the european consensus lupus activity measurement (ECLAM) and the modified systemic lupus erythematosus disease activity index 2000 (M-SLEDAI 2k) in juvenile systemic lupus erythematosus (JSLE) Sato, Juliana de Oliveira ; Corrente, José Eduardo ; Magalhães, Cláudia Saad (Annals Of The Rheumatic Diseases, 2014) [Resumo]
Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus Novak, Glaucia V.; Marques, Mariana; Balbi, Verena; Gormezano, Natali W.S.; Kozu, Kátia; Sakamoto, Ana P.; Pereira, Rosa M.R.; Terreri, Maria T.; Magalhães, Claudia S. ; Guariento, Andressa et al. (Autoimmunity Reviews, 2017) [Resenha]Background To our knowledge there are no studies assessing anti-Ro/SSA and anti-La/SSB autoantibodies in a large population of childhood-systemic lupus erythematosus (cSLE) patients. Methods This was a retrospective ...
ANTI-RO/SSA and/or ANTI-La/SSB Antibodies: Association with Mild LUPUS Manifestations in 645 Childhood-Onset Systemic LUPUS Erythematosus Novak, Glaucia V.; Marques, Mariana; Balbi, Verena; Gormezano, Natali W.; Kozu, Katia T.; Sakamoto, Ana Paula; Pereira, Rosa M. R.; Terreri, Maria Teresa; Magalhaes, Claudia S. ; Sacchetti, Silvana B. et al. (Arthritis & Rheumatology, 2016) [Resumo]